Core Viewpoint - Marex Group plc is facing a class action securities lawsuit due to alleged securities fraud that occurred between May 16, 2024, and August 5, 2025, which has adversely affected investors [1][2] Group 1: Lawsuit Details - The lawsuit claims that Marex Group plc made false statements and concealed information regarding the improper inflation of cash flow, revenues, assets, and profits in its Market Making segment through off-book intercompany transactions [2] - As a result of these actions, the positive statements made by the defendants about the Company's business and prospects were materially false and misleading [2] Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until December 8, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securing significant recoveries for shareholders and has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4]

Core Viewpoint - Marex Group plc is facing a class action securities lawsuit due to alleged securities fraud that occurred between May 16, 2024, and August 5, 2025, which has adversely affected investors [1][2]. Group 1: Lawsuit Details - The lawsuit claims that the defendants made false statements and concealed information regarding the improper inflation of cash flow, revenues, assets, and profits in the Market Making segment through off-book intercompany transactions [2]. - As a result of these actions, the positive statements made by the defendants about the Company's business and prospects were materially false and misleading [2]. Group 2: Investor Information - Investors who suffered losses during the specified time frame have until December 8, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and there is no obligation to participate [3]. Group 3: Legal Representation - Levi & Korsinsky, LLP has a strong track record in securing compensation for shareholders and has extensive expertise in complex securities litigation, with a team of over 70 employees [4].

Core Viewpoint - The Gross Law Firm is notifying shareholders of Marex Group plc regarding a class action lawsuit due to allegations of false statements and misleading information related to the company's financial performance [1][3]. Group 1: Allegations and Class Action Details - The class period for the lawsuit is from May 16, 2024, to August 5, 2025 [3]. - Allegations include that Marex Group improperly inflated its cash flow, revenues, assets, and profits in its Market Making segment through off-book intercompany transactions [3]. - The defendants' positive statements about the company's business and prospects were claimed to be materially false and misleading [3]. Group 2: Shareholder Actions and Deadlines - Shareholders are encouraged to register for the class action by December 8, 2025, to potentially be appointed as lead plaintiffs [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's status [4]. - Participation in the case incurs no cost or obligation for shareholders [4]. Group 3: Law Firm's Mission and Commitment - The Gross Law Firm aims to protect investors' rights who have suffered from deceit and illegal business practices [5]. - The firm is dedicated to ensuring companies adhere to responsible business practices and good corporate citizenship [5].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Marex Group plc due to allegations of securities law violations, with a deadline for investors to seek lead plaintiff status in a class action lawsuit by December 8, 2025 [3][5]. Summary by Sections Legal Investigation - Faruqi & Faruqi, LLP is a national securities law firm that has recovered hundreds of millions of dollars for investors since its inception in 1995 [4]. - The firm is encouraging investors who purchased Marex securities between May 16, 2024, and August 5, 2025, to discuss their legal rights [3][9]. Allegations Against Marex - The complaint against Marex alleges violations of federal securities laws, including making false or misleading statements and failing to disclose critical financial inconsistencies [5]. - Specific allegations include the sale of over-the-counter financial instruments to itself, inconsistencies in financial statements, and misleading positive statements about the company's operations and prospects [5]. NINGI Research Report - A report released by NINGI Research on August 5, 2025, accused Marex of a multi-year accounting scheme involving off-balance-sheet entities and fictitious transactions to hide losses and inflate profits [6]. - The report highlighted a fabricated receivable of $17 million, inflated subsidiary profits, and nearly $1 billion in concealed derivatives exposure [6]. Market Reaction - Following the release of the NINGI Research report, Marex's stock experienced a decline of 6.2%, closing at $35.31 with heavy trading volume [7].

Accessibility StatementSkip Navigation NEW YORK, Oct. 30, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Marex Group plc (NASDAQ: MRX). Shareholders who purchased shares of MRX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/marex-group-plc-loss-submission-form/?id=174491&f ...

Core Points - Rosen Law Firm is reminding investors who purchased Marex Group plc securities between May 16, 2024, and August 5, 2025, of the December 8, 2025, lead plaintiff deadline for a class action lawsuit [1] - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] Company Details - The lawsuit alleges that Marex made materially false and misleading statements, including selling over-the-counter financial instruments to itself and inconsistencies in financial statements between subsidiaries [4] - The misleading statements led to investors suffering damages when the true details were revealed [4] Legal Representation - Investors are encouraged to select qualified counsel with a successful track record in securities class actions, as many firms may not have the necessary experience [3] - Rosen Law Firm has a history of significant recoveries for investors, including over $438 million in 2019 alone [3]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Marex Group plc due to allegations of securities law violations, encouraging affected investors to contact them directly [1][3][4]. Group 1: Allegations Against Marex - The complaint alleges that Marex and its executives made false or misleading statements and failed to disclose critical information, including the sale of over-the-counter financial instruments to itself and inconsistencies in financial statements [3]. - A report from NINGI Research accused Marex of a multi-year accounting scheme involving off-balance-sheet entities and fictitious transactions to hide losses and inflate profits, citing a fabricated receivable of $17 million and nearly $1 billion in concealed derivatives exposure [4]. - Following the release of the report, Marex's stock experienced a significant decline of 6.2%, closing at $35.31 on heavy trading volume [5]. Group 2: Legal Proceedings and Investor Actions - The deadline for investors to seek the role of lead plaintiff in the federal securities class action against Marex is December 8, 2025, with the lead plaintiff being the investor with the largest financial interest [1][6]. - Faruqi & Faruqi encourages anyone with information regarding Marex's conduct, including whistleblowers and former employees, to come forward [6].

Core Viewpoint - Marex Group PLC is facing a class action lawsuit for allegedly misleading investors about its revenue projections and inflating its financial metrics through improper transactions [2][3]. Group 1: Company Overview - Marex Group PLC is a U.K.-based diversified global financial services platform listed on NASDAQ under the ticker MRX [1]. Group 2: Legal Allegations - The lawsuit claims that Marex Group failed to disclose that it improperly inflated its cash flow, revenues, assets, and profits in its Market Making segment through off-book intercompany transactions [3]. - As a result of these alleged actions, investors who sold short Marex Group securities during the class period have reportedly suffered significant losses [3]. Group 3: Class Action Participation - Shareholders who wish to serve as lead plaintiffs in the class action must submit their papers to the court by December 8, 2025 [4]. - Participation in the class action is not mandatory for recovery; shareholders can remain absent class members if they choose not to take action [4]. Group 4: Legal Representation - Robbins LLP, a firm specializing in shareholder rights litigation, is representing the class action on a contingency fee basis, meaning shareholders pay no fees or expenses unless there is a recovery [5].

Core Viewpoint - A class action lawsuit has been filed against Marex Group plc, alleging that the company concealed losses and inflated profits through deceptive financial practices during the specified class period [1][3]. Group 1: Lawsuit Details - The lawsuit is initiated by Berger Montague on behalf of investors who purchased Marex shares from May 16, 2024, to August 5, 2025 [1][2]. - Investors have until December 8, 2025, to seek appointment as lead plaintiff representatives [2]. Group 2: Allegations and Impact - NINGI Research published a report on August 5, 2025, claiming that Marex used off-balance-sheet entities and fictitious intercompany transactions to hide losses and inflate profits [3]. - Following the report, Marex's stock price fell by $2.33, or 6.2%, closing at $35.31, resulting in significant investor losses [3].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Marex Group plc during the specified Class Period of the upcoming lead plaintiff deadline on December 8, 2025, and the potential for compensation through a contingency fee arrangement [1][2]. Group 1: Class Action Details - The class action lawsuit against Marex Group plc alleges that during the Class Period, the company made materially false and misleading statements and failed to disclose critical information regarding its financial practices [4]. - Specific allegations include Marex selling over-the-counter financial instruments to itself, inconsistencies in financial statements between subsidiaries, and the unreliability of Marex's financial statements [4]. - The lawsuit claims that these misrepresentations led to investor damages when the true details became public [4]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [3]. - Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company at the time, and has recovered hundreds of millions for investors [3]. - The firm was ranked No. 1 for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013 [3].